View in EDS

Exploring published and novel pre-treatment CT and PET radiomics to stratify risk of progression among early-stage non-small cell lung cancer patients treated with stereotactic radiation.

Saved in:
Bibliographic Details
Title: Exploring published and novel pre-treatment CT and PET radiomics to stratify risk of progression among early-stage non-small cell lung cancer patients treated with stereotactic radiation.
Authors: Thor M; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, USA. Electronic address: thorm@mskcc.org., Fitzgerald K; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, USA., Apte A; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, USA., Oh JH; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, USA., Iyer A; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, USA., Odiase O; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, USA., Nadeem S; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, USA., Yorke ED; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, USA., Chaft J; Department of Medicine, Memorial Sloan Kettering Cancer Center, USA., Wu AJ; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, USA., Offin M; Department of Medicine, Memorial Sloan Kettering Cancer Center, USA., Simone II CB; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, USA., Preeshagul I; Department of Medicine, Memorial Sloan Kettering Cancer Center, USA., Gelblum DY; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, USA., Gomez D; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, USA., Deasy JO; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, USA., Rimner A; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, USA.
Source: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2024 Jan; Vol. 190, pp. 109983. Date of Electronic Publication: 2023 Nov 04.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0887
DOI:10.1016/j.radonc.2023.109983